Visualitzant O - Articles científics per títol

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

IACOBONI, GLORIA; Rejeski, Kai; Villacampa Javierre, Guillermo; van Doesum, Jaap; CHIAPPELLA, ANNALISA; Bonifazi, Francesca; Camacho-Arteaga, Lina ; Marin Niebla, Ana; Barba, Pere (American Society of Hematology, 2022-06-28)

Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma

Iacoboni García-Calvo, Gloria; Martinez-Cibrian, Nuria; Bailén, Rebeca; Corral, Lucia Lopez; Sanchez, Jose M.; Abrisqueta Costa, Pablo; Barba Suñol, Pere; Villacampa Javierre, Guillermo (Wiley, 2021-05)

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1

Dieras, Veronique; Cortés Castan, Javier; Patt, Debra; Wildiers, Hans; O’Shaughnessy, Joyce; Zamora Adelantado, Esther; Rugo, Hope (Springer, 2020-11)

Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer

Popat, Sanjay; Brustugun, Odd Terje; Cadranel, Jacques; Felip Font, Enriqueta; Garassino, Marina Chiara; Griesinger, Frank (Elsevier, 2021-07)

Recent advances in the targeting of epigenetic regulators in b-cell non- Hodgkin lymphoma

Ribeiro Lima, Marcelo; Reyes Garau, Diana; Armengol, Marc; Fernández Serrano, Miranda; Roue, Gael (Frontiers Media, 2019-10-16)

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

Vitiello, Pietro Paolo; Martini, Giulia; Ciardiello, Davide; Belli, Valentina; Matrone, Nunzia; Cardone, Claudia (BMC, 2019-01-28)

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

Vera, Ruth; Otero, M. J.; Ayala de la Peña, Francisco; González-Pérez, C.; Peñuelas Saiz, Angeles; Sepúlveda, Juan Manuel; Gorgas Torner, Maria Queralt (Springer, 2019-04)

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

Canaro Hirnyk, Mariana ; Sánchez-González, Blanca; Álvarez Román, María Teresa; Bárez-García, Abelardo; Bernardo, Angel; Mingot Castellano, María Eva; VALCARCEL, DAVID (MDPI, 2023-10-10)

Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma

Zacarias Fluck, Mariano F; Massó-Vallés, Daniel; Giuntini, Fabio; González-Larreategui, Íñigo; Kaur, Jastrinjan; Casacuberta-Serra, Sílvia; Jauset González, Antoni; Martínez Martín, Sandra; Martín Fernández, Génesis; Serrano del Pozo, Erika; Foradada Felip, Laia; Grueso Gragera, Judit; Nonell Malezon, Lara; Whitfield, Jonathan; Beaulieu, Marie-Eve; Soucek, Laura (Cold Spring Harbor Laboratory Press, 2023-04-01)

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype

Mallo, Maria del Mar; Tuechler, Heinz; Arenillas, Leonor; Raynaud, Sophie; Cluzeau, Thomas; Shih, Lee-Yung; Palomo Diaz, Laura (Wiley, 2023-05)

Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas

Profitós-Pelejà, Núria; Carvalho Santos, Juliana; Roue, Gael; Ribeiro, Marcelo; Marin Niebla, Ana (MDPI, 2022-02-09)

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study

Colombo, Nicoletta; Van Gorp, Toon; Grisham, Rachel; Fleming, Gini; Matulonis, Ursula; OAKNIN, ANA (American Society of Clinical Oncology, 2023-10-20)

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition

Jiménez Bernal, Isabel; Carabia Juberó, Júlia; Bobillo Varela, Sabela; Palacio García, Carlos; Abrisqueta Costa, Pablo; Pagès Geli, Carlota; Nieto Sáchica, Juan Camilo; Castellví Vives, Josep; Martínez Ricarte, Francisco Ramón; Boix, Joan; Purroy Zuriguel, Noelia; Puigdefabregas Horta, Lluis; Seoane Suarez, Joan; Bosch Albareda, Francesc; Crespo Maull, Marta (Springer, 2020-08)

Reporting reimbursement price decisions for onco-hematology drugs in Spain

Elvira-Martinez, David; Torres, Ferran; Puig, Gemma; Obach, Merce; Gay, Daniel; Vives, Roser; Tabernero, Josep (Frontiers Media, 2023-10-24)

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Saini, Kamal S.; Lanza, Carlo; Romano, Marco; de Azambuja, Evandro; Cortés Castan, Javier; de las Heras, Begoña (Springer Nature, 2020-09)

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Stein, Eytan M.; DeAngelo, Daniel; Chromik, Jörg; Chatterjee, Manik; Bauer, Sebastian; Lin, Chia-Chi; Suárez Rodríguez, Cristina; Carpio Segura, Cecilia Carmen (American Association for Cancer Research, 2023-03-01)

Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy

Alonso-Gordoa, Teresa; Reig Torras, Oscar; Esteban, Emilio ; Castellano, D.; Garcia del Muro, Xavier; González Rodríguez, Macarena; Grande, Enrique (Elsevier, 2022-04)

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer

Gardner, Faithlore P.; Fountzilas, Christos; Bahary, Nathan; Womack, Mark S.; Wainberg, Zev; Macarulla, Teresa (MDPI, 2024-03-28)

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform

Morfouace, Marie; Novello, S.; Stevovic, A.; Dooms, C.; Janzic, Urska; Felip Font, Enriqueta; Berghmans, Thierry (Nature Portfolio, 2022-05-18)

Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward

Lostes Bardaji, M Julia; García Illescas, David; Valverde Morales, Claudia Maria; Serrano Garcia, César (SAGE Publications, 2021-01)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1

Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer

Recent advances in the targeting of epigenetic regulators in b-cell non- Hodgkin lymphoma

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype

Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition

Reporting reimbursement price decisions for onco-hematology drugs in Spain

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform

Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma ﻿

Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma ﻿

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1 ﻿

Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer ﻿

Recent advances in the targeting of epigenetic regulators in b-cell non- Hodgkin lymphoma ﻿

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines ﻿

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients ﻿

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI) ﻿

Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma ﻿

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype ﻿

Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas ﻿

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study ﻿

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition ﻿

Reporting reimbursement price decisions for onco-hematology drugs in Spain ﻿

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy ﻿

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia ﻿

Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy ﻿

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer ﻿

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform ﻿

Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1

Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer

Recent advances in the targeting of epigenetic regulators in b-cell non- Hodgkin lymphoma

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype

Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition

Reporting reimbursement price decisions for onco-hematology drugs in Spain

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer

Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform

Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward